Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. (ELDN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
eldn · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$5.00
+39.7% upside
Low
$5.00
Median: $5 · Last Close: $3.58
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.40 | ↓ 5.00% |
1-day model range: $3.38–$3.42. Peak: $3.42 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ELDN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Guggenheim | Maintains | Buy→Buy |
| 2025-09-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-22 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Eledon Pharmaceuticals, Inc. (ELDN) stock. Of the recent 16 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover ELDN.
Analyst Recommendation Trends
ELDN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-0.87
EPS Next Year
$-0.78
↓ 10.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast ELDN EPS of $-0.87 for the current fiscal year, based on estimates from 3 analysts. The ELDN revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ELDN stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ELDN price target is $5.00 (+39.7% upside), with an analyst consensus of Buy.
The ELDN short-term stock prediction for tomorrow is $3.40 (-5.00%).
Eledon Pharmaceuticals, Inc. trades on NASDAQ under the ticker ELDN. The ELDN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
ELDN forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month ELDN price target is $5.00, with a high forecast of $5.00 and a low of $5.00. The median price target is shown in the chart above when available. This implies +39.7% potential upside from the current price of $3.58.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.